Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1975

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1975). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

A line graph showing mean plasma concentrations of dextroamphetamine and levoamphetamine over 24 hours. It compares extended-release capsules 20 mg once daily and tablets 10 mg twice daily formulations of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. The x-axis represents time in hours, and the y-axis represents mean plasma concentrations in ng/mL.*

FDA Label Image

Label (Lbl636291975)

Label for Dextroamphetamine Sulf-Saccharate/Amphetamine Sulf-Aspartate ER, USP 20 mg extended-release capsules. The label indicates a package size of 100 capsules, with the product manufactured by UPM Pharmaceuticals and relabeled by Bryant Ranch Prepack. Storage and handling instructions are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.